PCIA
NVO

Prime Capital Investment Advisors’s Novo Nordisk NVO Stock Holding History

Prime Capital Investment Advisors’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.71M Sell
56,457
-1,448
-3% -$62.2K 0.03% 334
2026
Q1 		$2.13M Buy
57,905
+365
+0.6% +$17.3K 0.02% 350
2025
Q4 		$2.93M Sell
57,540
-1,061
-2% -$54.3K 0.04% 286
2025
Q3 		$3.25M Sell
58,601
-14,618
-20% -$856K 0.04% 268
2025
Q2 		$5.05M Buy
73,219
+7,998
+12% +$544K 0.07% 197
2025
Q1 		$4.53M Buy
65,221
+2,609
+4% +$215K 0.05% 238
2024
Q4 		$5.39M Sell
62,612
-1,579
-2% -$171K 0.08% 172
2024
Q3 		$7.64M Sell
64,191
-9,497
-13% -$1.27M 0.11% 139
2024
Q2 		$10.5M Sell
73,688
-11,423
-13% -$1.51M 0.16% 109
2024
Q1 		$10.9M Sell
85,111
-23,515
-22% -$2.8M 0.15% 117
2023
Q4 		$11.2M Buy
108,626
+93,307
+609% +$9.23M 0.17% 115
2023
Q3 		$1.39M Sell
15,319
-787
-5% -$69.3K 0.03% 301
2023
Q2 		$1.3M Buy
16,106
+7,902
+96% +$646K 0.03% 312
2023
Q1 		$653K Sell
8,204
-136
-2% -$9.64K 0.03% 306
2022
Q4 		$564K Buy
8,340
+2,330
+39% +$137K 0.02% 313
2022
Q3 		$299K Buy
6,010
+108
+2% +$5.79K 0.02% 305
2022
Q2 		$329K Sell
5,902
-256
-4% -$14.2K 0.02% 282
2022
Q1 		$345K Hold
6,158
– – 0.02% 280
2021
Q4 		$345K Buy
6,158
+256
+4% +$13.9K 0.02% 280
2021
Q3 		$283K Sell
5,902
-1,002
-15% -$48.4K 0.02% 254
2021
Q2 		$289K Sell
6,904
-140
-2% -$5.43K 0.02% 313
2021
Q1 		$237K Buy
7,044
+5,780
+457% +$206K 0.02% 235
2020
Q4 		$44K Sell
1,264
-28
-2% -$968 ﹤0.01% 334
2020
Q3 		$45K Sell
1,292
-104
-7% -$3.47K ﹤0.01% 326
2020
Q2 		$46K Buy
1,396
+500
+56% +$16K ﹤0.01% 330
2020
Q1 		$27K Sell
896
-78
-8% -$2.32K ﹤0.01% 331
2019
Q4 		$28K Sell
974
-104
-10% -$2.88K ﹤0.01% 369
2019
Q3 		$28K Buy
+1,078
New +$27.3K ﹤0.01% 374

Other funds holding NVO

Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
EHC
Everett Harris & Co Los Angeles, California $8.14B AUM 14.79% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $146B AUM 55.73% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SRIM
Saratoga Research & Investment Management Saratoga, California $1.83B AUM 18.41% 1-Year Est. Return
Bank of Nova Scotia
Bank of Nova Scotia Toronto, Ontario, Canada $66.2B AUM 46.3% 1-Year Est. Return

Prime Capital Investment Advisors's NVO Position: Q2 2026 in Review

Prime Capital Investment Advisors reduced its Novo Nordisk (NVO) stake by 2.5% in Q2 2026, selling an estimated $62.2K and leaving 56,457 shares worth $2.71M. The position accounts for 0.03% of the portfolio, ranked #334.

Prime Capital Investment Advisors first reported a position in NVO in Q3 2019 and has held it in 28 quarters since. The position peaked at $11.2M in Q4 2023. 1,041 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

  • Prime Capital Investment Advisors held 56,457 shares of Novo Nordisk worth $2.71M as of Q2 2026.
  • Prime Capital Investment Advisors sold 1,448 Novo Nordisk shares in Q2 2026, an estimated $62.2K.
  • Novo Nordisk made up 0.03% of Prime Capital Investment Advisors's portfolio in Q2 2026, its #334 holding.
  • Prime Capital Investment Advisors first reported a position in Novo Nordisk in Q3 2019 and has held it in 28 quarters since.
  • Prime Capital Investment Advisors's Novo Nordisk position peaked at $11.2M in Q4 2023.
  • 1,041 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on Prime Capital Investment Advisors's 13F filing for Q2 2026, filed 5 Aug 2026.